Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma.
Dharshan SivarajMichael M GreenYubin KangGwynn D LongDavid A RizzieriZhiguo LiAnderson H GarrettJackie L McIntyreNelson J ChaoCristina GasparettoPublished in: Blood cancer journal (2018)